# Engineering of Corynebacterium glutamicum for the enhanced production of optically pure (meso)-2,3-butanediol

**Authors:** Eun Seo Song, Kyeong Ho Kim, Joon Young Lee, Ki Jun Jeong

PMC · DOI: 10.1186/s40643-026-01025-4 · 2026-03-25

## TL;DR

Scientists engineered a bacterium to produce high-purity (meso)-2,3-butanediol, a valuable chemical, with record efficiency and optical purity.

## Contribution

First demonstration of >100 g/L optically pure (meso)-2,3-BDO using a plasmid-free C. glutamicum strain through enzyme engineering and pathway optimization.

## Key findings

- Engineered C. glutamicum strain ES11 achieved 100.4 g/L (meso)-2,3-BDO with >99% optical purity.
- Structure-guided engineering of KpBDH improved catalytic efficiency and stereoselectivity.
- Integrated pathway optimization and cofactor regeneration enhanced productivity and yield.

## Abstract

2,3-Butanediol (2,3-BDO) is a versatile platform chemical with diverse applications in cosmetics, pharmaceuticals, agricultural and food manufacturing. Among its stereoisomers, optically pure (meso)-2,3-BDO is particularly valuable; however, achieving high titers with stereoselectivity remains challenging in conventional hosts due to byproduct formation, low tolerance, and plasmid instability. In this study, we established Corynebacterium glutamicum as an efficient and robust chassis for the industrial-level production of optically pure (meso)-2,3-BDO. A structure-guided engineering approach was applied to 2,3-butanediol dehydrogenase (KpBDH), where α6-helix truncation enhanced catalytic efficiency and enabled near-complete conversion of acetoin to the target isomer. To further improve productivity, competing byproduct pathways were deleted, and cofactor homeostasis was reinforced by integrating UdhA for NADH regeneration and DrPPK for ATP regeneration. Finally, all biosynthetic modules were stably integrated into the chromosome, generating the plasmid-free strain ES11. In 5L fed-batch fermentation, ES11 produced 100.4 ± 0.4 g/L (meso)-2,3-BDO with > 99% optical purity, a yield of 0.33 ± 0.04 g/g glucose, and productivity of 0.82 ± 0.06 g/L/h. This work represents the first demonstration of > 100 g/L optically pure (meso)-2,3-BDO using C. glutamicum and establishes an integrated strategy of enzyme engineering, pathway optimization, and process design.

The online version contains supplementary material available at 10.1186/s40643-026-01025-4.

## Linked entities

- **Genes:** udhA (oxidoreductase) [NCBI Gene 1026046]
- **Chemicals:** 2,3-butanediol (PubChem CID 262), (meso)-2,3-butanediol (PubChem CID 262), acetoin (PubChem CID 179), NADH (PubChem CID 439153), ATP (PubChem CID 5957)
- **Species:** Corynebacterium glutamicum (taxon 1718)

## Full-text entities

- **Diseases:** BDH (MESH:D015325), RBS (MESH:D009371), toxicity (MESH:D064420)
- **Chemicals:** imidazole (MESH:C029899), lactate (MESH:D019344), carbon (MESH:D002244), methanol (MESH:D000432), oxygen (MESH:D010100), diacetyl (MESH:D003931), ethanol (MESH:D000431), calcium pantothenate (MESH:D010205), Casamino acid (MESH:C017721), amino acid (MESH:D000596), NiCl2 (MESH:C022838), 1,3-butadiene (MESH:C031763), chloroform (MESH:D002725), chloramphenicol (MESH:D002701), Thiamine (MESH:D013831), succinate (MESH:D019802), diphosphates (MESH:D011756), K2HPO4 (MESH:C013216), (2R,3R)-2,3-BDO (-), nickel (MESH:D009532), NAD+ (MESH:D009243), methyl ethyl ketone (MESH:C005222), polymer (MESH:D011108), biotin (MESH:D001710), (NH4)2SO4 (MESH:D000645), CaCl2 (MESH:D002122), glycerol (MESH:D005990), TCA (MESH:D014238), water (MESH:D014867), ZnSO4 (MESH:D019287), alpha-acetolactate (MESH:C006359), acetoin (MESH:D000093), NaCl (MESH:D012965), Glucose (MESH:D005947), nitrogen (MESH:D009584), Urea (MESH:D014508), H2SO4 (MESH:C033158), NaOH (MESH:D012972), TALON (MESH:C013418), acetate (MESH:D000085), Kanamycin (MESH:D007612), Sodium acetate (MESH:D019346), ammonia (MESH:D000641), acetyl-CoA (MESH:D000105), ampicillin (MESH:D000667), 2,3-BDO (MESH:C026978), sucrose (MESH:D013395), PYR (MESH:D019289), formamide (MESH:C031066), ATP (MESH:D000255), polyphosphate (MESH:D011122), sorbitol (MESH:D013012)
- **Species:** Corynebacterium glutamicum ATCC 13032 (strain) [taxon 196627], Corynebacterium glutamicum (species) [taxon 1718], Bacillus subtilis subsp. subtilis (subspecies) [taxon 135461], Klebsiella oxytoca (species) [taxon 571], Bacillus subtilis subsp. subtilis str. 168 (strain) [taxon 224308], Enterobacter cloacae (species) [taxon 550], Klebsiella michiganensis KCTC 1686 (strain) [taxon 1006551], Bacillus licheniformis (species) [taxon 1402], Escherichia coli BL21(DE3) (strain) [taxon 469008], Escherichia coli str. K-12 substr. MG1655 (no rank) [taxon 511145], Serratia marcescens (species) [taxon 615], Bacillus subtilis (species) [taxon 1423], Escherichia coli (E. coli, species) [taxon 562], Deinococcus radiodurans (species) [taxon 1299], Klebsiella pneumoniae (species) [taxon 573], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** C with 200, C for 6-8
- **Cell lines:** 33 — Mus musculus (Mouse), Hybridoma (CVCL_J975), ES10 — Homo sapiens (Human), Embryonic stem cell (CVCL_C767), ES11 — Homo sapiens (Human), Transformed cell line (CVCL_C1JD), ES7 — Homo sapiens (Human), Embryonic stem cell (CVCL_C774), ES8 — Homo sapiens (Human), Embryonic stem cell (CVCL_C775), ES1-ES11 — Homo sapiens (Human), Ewing sarcoma, Cancer cell line (CVCL_1198), ES8_33 — Mus musculus (Mouse), Hybridoma (CVCL_J913), ES5 — Homo sapiens (Human), Embryonic stem cell (CVCL_C772), Escherichia coli Mega X DH10B — Homo sapiens (Human), Transformed cell line (CVCL_C5VU), ES4_26 — Rattus norvegicus (Rat), Transformed cell line (CVCL_8806), ES4 B — Homo sapiens (Human), Embryonic stem cell (CVCL_C771), -22b — Mus musculus (Mouse), Adenoma of the mouse pulmonary system, Cancer cell line (CVCL_5U98)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018514/full.md

---
Source: https://tomesphere.com/paper/PMC13018514